About Us

ABM Therapeutics is a leading innovative drug discovery company focusing on small molecule targeted therapy for the possible treatments of brain cancers including GBM, as well as brain metastasis from lung cancer, breast cancer and melanoma. Founded by an experienced group of scientists and entrepreneurs with successful track record, we are committed to diligently search and deliver best-in-class and first-in-class medicines for the needed patients worldwide.


ABM Therapeutics will report the study progress of its ongoing ABM-1310 Phase 1 trial at 2...


Read more

ABM Announces First Patient Dosed in Phase I Clinical Trial of MEK Inhibitor for Solid Tum...


Read more

Meet ABM Therapeutics at AACR Annual Meeting 2023 ...


Read more

© 2019 Wall Calvin technology.Powered by Webfoss.

Legal claim|Privacy policy